This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_RETINOBLAST_EXALLC for full statistics.
Retinoblastoma
C3_RETINOBLAST
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
28 |
4. Check minimum number of eventsNone |
28 |
5. Include endpointsNone |
28 |
6. Filter based on genotype QC (FinnGen only) |
28 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Retinoblastoma
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of eye and adnexa
- Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of eye, brain and central nervous system
- Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 28 | 17 | 11 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.00 |
| Median age at first event (years) | 2.49 | 2.62 | 2.30 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42870588) Differential panel, method unspecified - Blood
20
77
6.54
5.21
18.0
6.3
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
7
11
8.04
3.42
4.1
30.5
%
97.4
94.5
—
7
11
(4035726)
7
12
7.35
3.24
1.9
1.2
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
6
8
9.14
3.22
4.7
2.5
%
160.5
198.9
—
6
8
(3044640) Blood type and Crossmatch panel - Blood
14
57
3.91
3.04
7.4
3.6
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
13
51
3.89
2.96
10.8
7.6
%
90.8
93.3
0.11
13
51
(3018677) aPTT in Platelet poor plasma by Coagulation assay
9
25
4.79
2.89
4.9
18.8
s
33.5
33.7
—
9
25
(3020630) Protein [Mass/volume] in Serum or Plasma
5
6
9.77
2.86
24.4
1.0
g/l
62.2
62.5
—
5
6
(3020779) Urea [Moles/volume] in Serum or Plasma
7
16
5.45
2.67
11.6
16.8
mmol/l
5.2
5.6
—
7
16
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
15
69
3.53
2.65
3.6
2.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
16
79
3.39
2.49
3.4
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
11
43
3.57
2.45
7.5
4.0
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
5
9
6.47
2.31
5.2
14.2
g/l
3.7
3.9
—
5
9
(3037522) Nuclear Ab [Titer] in Serum
8
25
4.05
2.31
1.6
1.5
—
368.0
—
0
5
(3005719) IgG [Mass/volume] in Serum or Plasma
7
20
4.30
2.22
2.9
3.6
g/l
6.9
9.5
—
7
20
(3019225) pH of Specimen
6
15
4.78
2.17
7.0
4.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
10
5.81
2.16
1.2
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
7
24
3.53
1.86
1.3
1.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
7
24
3.53
1.86
5.0
2.5
umol/l
13.8
12.9
—
7
24
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
16
90
2.81
1.84
6.8
6.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
18
108
2.87
1.83
23.1
10.2
e9/l
0.0
0.0
0.00
13
86
(36304419) Bacteria [Presence] in Urine
12
62
2.64
1.57
3.7
2.3
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
6
23
3.03
1.45
1.5
1.7
u/ml
22.2
129.3
—
6
23
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
8
35
2.79
1.41
1.3
1.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
14
82
2.41
1.39
3.1
2.4
nmol/l
84.4
71.9
0.84
14
73
(3037467) Urinalysis macro (dipstick) panel - Urine
20
145
2.32
1.31
6.9
3.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
9
45
2.46
1.20
5.6
5.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
5
21
2.67
1.14
8.2
20.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
5
22
2.54
1.08
34.6
4.6
mmol/l
24.2
24.3
—
5
22
(40758558) Short blood count panel - Blood
11
66
2.10
0.96
34.8
8.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
8
46
2.03
0.92
1.6
1.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
8
47
1.98
0.90
4.5
2.3
umol/l
295.0
299.5
—
8
42
(3021447) Carbon dioxide [Partial pressure] in Venous blood
6
33
2.04
0.84
30.2
3.8
kpa
5.8
5.8
—
6
33
(3013512) EKG study
7
40
1.99
0.79
4.0
2.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
5
28
1.95
0.70
36.2
9.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
22
185
1.88
0.68
6.6
4.5
mmol/mol
36.3
38.4
0.55
22
174
(3012544) pH of Venous blood
6
34
1.97
0.64
29.8
4.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
19
153
1.75
0.64
6.5
3.3
u/l
34.4
39.4
0.27
19
146
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
0
20
0.00
0.63
0.0
2.2
—
20.1
—
0
6
(3015736) pH of Urine
12
84
1.75
0.63
3.8
2.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
19
0.00
0.63
0.0
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
0
21
0.00
0.63
0.0
1.1
—
4.1
—
0
12
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
6
37
1.79
0.60
1.5
2.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
14
108
1.59
0.48
5.4
2.9
ug/l
97.5
81.7
0.23
14
103
(3024354) Oxygen [Partial pressure] in Venous blood
5
30
1.81
0.47
33.8
4.0
kpa
4.8
4.8
—
5
30
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
9
65
1.56
0.45
1.6
1.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
0
15
0.00
0.42
0.0
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
0
15
0.00
0.42
0.0
1.5
—
0.5
—
0
5
(3004716) Salmonella sp identified in Stool by Organism specific culture
0
16
0.00
0.42
0.0
1.4
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
28
263
+∞
0.42
48.1
18.8
g/l
134.5
136.3
0.23
28
258
(3035941) MCH [Entitic mass]
28
263
+∞
0.42
46.5
18.7
pg
30.6
29.7
1.63
28
258
(3026361) Erythrocytes [#/volume] in Blood
28
263
+∞
0.42
46.8
18.7
e12/l
4.5
4.6
0.66
28
255
(3024731) MCV [Entitic volume]
28
263
+∞
0.42
46.5
18.7
fl
90.5
88.8
0.84
28
258
(3007461) Platelets [#/volume] in Blood
28
263
+∞
0.42
46.7
18.8
e9/l
256.9
268.4
0.47
28
255
(3010813) Leukocytes [#/volume] in Blood
28
263
+∞
0.42
46.8
19.0
e9/l
6.7
6.7
0.01
28
255
(3010726) Horse dander IgE Ab [Units/volume] in Serum
0
17
0.00
0.42
0.0
1.1
—
0.0
—
0
5
(3003888) Timothy IgE Ab [Units/volume] in Serum
0
18
0.00
0.41
0.0
1.1
—
8.2
—
0
11
(3008401) Mugwort IgE Ab [Units/volume] in Serum
0
18
0.00
0.41
0.0
1.1
—
5.0
—
0
12
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6
40
1.63
0.40
1.7
2.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
7
51
1.49
0.35
1.1
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
7
53
1.43
0.34
2.0
1.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
8
65
1.32
0.31
1.3
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
11
0.00
0.22
0.0
1.6
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
11
0.00
0.22
0.0
1.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
11
0.00
0.22
0.0
1.6
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
11
0.00
0.22
0.0
1.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
10
0.00
0.22
0.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
10
0.00
0.22
0.0
2.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
10
0.00
0.22
0.0
1.7
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
10
0.00
0.22
0.0
1.7
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
10
0.00
0.22
0.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.22
0.0
1.8
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
0
10
0.00
0.22
0.0
1.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
0
12
0.00
0.21
0.0
1.9
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
6
50
1.25
0.21
4.0
2.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
7
56
1.33
0.21
3.7
2.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
14
126
1.22
0.12
16.3
9.1
mmol/l
6.1
6.3
0.17
14
112
(3019550) Sodium [Moles/volume] in Serum or Plasma
23
220
1.25
0.09
42.8
15.7
mmol/l
139.7
139.6
0.06
23
209
(3003338) MCHC [Mass/volume]
21
217
0.87
0.09
42.1
16.3
g/l
336.0
334.6
0.37
21
217
(3041096) Erythrocytes [Presence] in Urine by Automated
7
64
1.12
0.09
3.3
2.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
7
64
1.12
0.09
23.4
4.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
8
76
1.07
0.08
2.3
2.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
9
85
1.09
0.08
2.3
2.4
—
—
—
0
0
(3044889) 12 lead EKG panel
12
131
0.85
0.07
4.4
2.7
—
—
—
0
0
(3020891) Body temperature
0
9
0.00
0.00
0.0
4.8
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
26.0
—
0
5
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
7.2
—
0
5
(3007566) Smooth muscle Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
0
8
0.00
0.00
0.0
12.0
—
1.2
—
0
8
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
22
217
1.06
0.00
3.6
4.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
8
83
0.95
0.00
4.4
2.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
0
7
0.00
0.00
0.0
71.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
23
223
1.18
0.00
42.5
15.5
mmol/l
3.9
4.0
0.68
23
211
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4034850)
0
6
0.00
0.00
0.0
7.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_RETINOBLAST – Retinoblastoma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).